Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-23

Clinical Trial Update: Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura

View source ↗

Summary

This clinical trial update describes research aimed at identifying biomarkers that predict worse prognosis in Henoch-Schönlein purpura.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Purpura, Schoenlein-Henoch | Status: UNKNOWN